Monday, December 08, 2025 | 05:15 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

News digest: S&P holds India rating, insolvency ordinance, and more

National drug pricing regulator NPPA on Friday said it has capped prices of 51 essential formulations, including those used for the treatment of cancer, pain, heart conditions and skin problems

news digest
premium

News digest

BS Web
S&P refuses to do a Moody's; maintains status quo on India's rating

Credit rating agency Standard & Poor’s (S&P) on Friday retained India’s sovereign rating at the lowest investment grade with a stable outlook. It attributed its decision to a weak fiscal position, particularly of states, high government debt, and low per capita income.

S&P’s rating remains at BBB-, one notch above junk and a notch below what Moody’s Investors Service upgraded India to recently. Read more

India needs to look beyond Buenos Aires, says Suresh Prabhu

With a little over a fortnight left before the World Trade